Patient Safety Culture monitoring

Roadmap for a Patient Safety Culture - Monitoring by Means of Surveys... 

One means of gathering data for monitor indicators is patient safety culture questionnaires. We have developed a patient safety culture questionnaire, TUKU, that measures employees perceptions of the organisational functions depicted in Table 9.4 as well as employees psychological states, such as sense of control and worry about patient safety (Reiman et al. 2013). In one hospital, the results of the questionnaire were compared with the ratio of patient safety incidents at the hospital s 40 units 16 months after the safety culture questionnaire was administered. The results, which must be treated with caution due to the small sample size, indicated that perceptions of work process management , work conditions management . 

How, then, can a system such as that outlined by Wachter be established in a hospital How can a stracture and culture be developed in which employees are mindful and in which lessons are learned from incidents on a continuous and systematic basis Is the design of learning processes the major lever that can bring about a positive patient safety culture And how can continuous monitoring of patient safety culture contribute to this development ... 

The safety culture criteria depicted in Table 9.1 can be understood as the goals or ideal end states of patient safety management and they can be used as a frame to define monitor indicators. Organisational activities can be viewed from the point of view of how they contribnte to these six ideal states. The control functions in Table 9.2 on the other hand can be used for selecting drive indicators that facilitate change in the right direction. 

Thus, they established procedures for clinical trials and other experimentation with humans in which researchers are expected to follow a precautionary protocol for selecting patients and applying experimental methods and products to them, monitoring their response, and then do full and timely reporting of any adverse outcomes to enable open discussion and evaluation of the causes, quick determination of corrective actions needed for patient safety, and rapid dissemination and implementation of the corrective actions in all related research projects. It now appears that this model for safeguarding human subjects needs reinforcement for it to be sufficient in the competitive and economically opportunistic culture in which gene therapies are tested. 

---